Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00016588
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
2001-05-17
Brief Title:
Tenofovir Disoproxil Fumarate TDF in HIV-1 Patients Who Have Never Taken Anti-HIV Drugs
Sponsor:
Gilead Sciences
Organization:
NIH AIDS Clinical Trials Information Service
Study Overview
Official Title:
An Open-Label Study to Assess the Anti-HIV-1 Activity of Tenofovir Disoproxil Fumarate TDF in Antiretroviral-Naive Patients Who Are Chronically Infected With HIV-1
Status:
COMPLETED
Status Verified Date:
2002-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to look at the effectiveness of tenofovir disoproxil fumarate TDF in HIV-infected patients who have never taken anti-HIV drugs
Detailed Description:
Patients receive TDF
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| GS-00-917 | None | None | None |